Sri Chakra Cement Limited (BOM:518053)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2021	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Mar 31, 2024	Dec 31, 2021	Mar 31, 2021	Mar 31, 2020
Net Income	-568.29	-106.5	-	96.23	-117.75
Depreciation & Amortization	124.65	106.05	-	96.65	75.91
Loss (Gain) From Sale of Investments	-2.72	-3.35	-	-	-0.08
Other Operating Activities	22.4	6.41	-	11.72	11.14
Change in Accounts Receivable	58.52	19.71	-	22.94	-31.8
Change in Inventory	77.27	-46.86	-	10.33	51.7
Change in Accounts Payable	138.19	23.53	-	-46.73	72.3
Change in Income Taxes	-1.43	-0.54	-	-11.23	12.71
Change in Other Net Operating Assets	130.79	637.86	-	-124.29	66.71
Operating Cash Flow	-34.23	642.99	-	49.1	123.72
Operating Cash Flow Growth	-	-	-	-60.31%	256.40%
Capital Expenditures	-12.88	-96.95	-	-7.93	-158.36
Investment in Securities	-	-	-	-	0.08
Other Investing Activities	2.72	3.35	-	-	-
Investing Cash Flow	-10.16	-93.59	-	-7.93	-158.28
Long-Term Debt Issued	68.2	-	-	89.49	86
Long-Term Debt Repaid	-	-526.89	-	-	-
Net Debt Issued (Repaid)	68.2	-526.89	-	89.49	86
Other Financing Activities	-32.58	-20.64	-	-53.16	-42.53
Financing Cash Flow	35.62	-547.53	-	36.33	43.47
Miscellaneous Cash Flow Adjustments	-	-	-	0	-0
Net Cash Flow	-8.78	1.87	-	77.5	8.91
Free Cash Flow	-47.11	546.04	-	41.17	-34.64
Free Cash Flow Margin	-4.24%	23.99%	-	2.20%	-2.46%
Free Cash Flow Per Share	-5.23	60.67	-	4.27	-3.87
Cash Interest Paid	21.79	7.54	-	12.12	11.71
Levered Free Cash Flow	174.26	-	-	-23.92	60.51
Unlevered Free Cash Flow	201.83	-	-	24.82	103.05
Change in Net Working Capital	-426.32	-	-	162.19	-232.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.